Some providers featured on this site may compensate us. This may affect the order and placement of listings but does not influence our editorial ratings or reviews.
Treatments Hub

Verified prices

All verified prices
Comparison8 min read

Zepbound vs Wegovy vs Ozempic (2026): Full Comparison

Zepbound (tirzepatide) led trials with up to 22.5% average weight loss vs ~15% for Wegovy (semaglutide); Ozempic is the diabetes-approved sibling. Verified prices from $59/month compounded to $1,249 brand.

Updated September 15, 2026

Medically reviewed on

How we review

The quick answerZepbound (tirzepatide) produced up to 22.5% average weight loss in trials versus ~15% for Wegovy (semaglutide); Ozempic is the same semaglutide under its diabetes label. Verified prices: brand Zepbound $1,249/month and Wegovy $1,579 at altRx, versus compounded semaglutide from $41 and tirzepatide from $71 through licensed telehealth.Prices verified on each provider’s site as of November 3, 2026.

Key takeaways

  • Zepbound (tirzepatide) targets two hormone receptors and produced up to 22.5% average weight loss in trials, vs ~15% for Wegovy (semaglutide).
  • Ozempic contains Wegovy's ingredient at diabetes-approved dosing - it's the same semaglutide, different label.
  • Verified brand prices: Zepbound $1,249/mo and Wegovy $1,579 at altRx; compounded routes run $59-$99/month.
  • There is no DIY dose conversion between them - switching means restarting titration with your prescriber.

What's the difference between Zepbound, Wegovy and Ozempic?

Three names, two drugs, three FDA labels. Zepbound is tirzepatide, FDA-approved for chronic weight management - it targets two hormone receptors (GIP and GLP-1). Wegovy is semaglutide at weight-management dosing (up to 2.4 mg). Ozempic is the same semaglutide approved for type 2 diabetes at up to 2 mg - widely used off-label for weight loss, but the weight-loss approval belongs to Wegovy. So the real comparison is tirzepatide vs semaglutide, with Ozempic as semaglutide's diabetes-label sibling - our molecule-level comparison goes deeper.

Our top 2 picks

Our two recommended GLP-1 providers, shown with the same verified pricing and ratings as our full comparison.

Our Top Pick
1
embody logo

Exceptional

9.8out of 10

Compounded GLP-1 from $49/month; not FDA-approved, free expedited delivery

Free expedited deliveryNo hidden fees
  • Compounded semaglutide ($49/mo) and tirzepatide ($99/mo) as shown on the homepage, Nov 16, 2026; not FDA-approved
  • Online intake, then a prescriber review by OpenLoop Health, a network of US-licensed doctors
  • Free expedited delivery (embody's words); the Terms do not guarantee a delivery timeline
  • No insurance required, no clinic visits; cancel at least 72 hours before the next billing date

from $49/month

Doctor-prescribed compounded GLP-1 treatment, not FDA-approved: semaglutide shown at $49/month and tirzepatide at $99/month on embody's homepage (Nov 16, 2026), no insurance required. Rated 3.8 across 10,689 Trustpilot reviews (Oct 25, 2026).

Read full embody review
2
altRx logo

Excellent

9.4out of 10

Most Comprehensive GLP-1 Medication Access

Transparent pricingNo insurance required
  • Compounded GLP-1 from $89/mo, GLP-1 + GIP from $149/mo
  • Brand-name options too: Zepbound and Wegovy
  • Clinician-guided - physician, PA, or nurse practitioner
  • Free shipping (about 5-7 days)

from $89/month

Affordable GLP-1 program from $89/month - compounded semaglutide and tirzepatide plus brand-name options - with clinician-guided, self-pay care and no insurance required.

Read full altRx review

Which is stronger - Zepbound or Wegovy?

On trial averages, Zepbound. Tirzepatide produced up to 22.5% average body-weight loss in its trials at the highest dose, versus roughly 15% for semaglutide in Wegovy's pivotal trial - a meaningful gap, with the usual honest caveats: averages hide individual variation, the drugs weren't compared head-to-head in those trials, and tolerability differs person to person.

Plenty of people respond excellently to semaglutide; some tolerate one and not the other. "Stronger on average" is true; "stronger for you" is what titration under a clinician discovers.

What do they cost out of pocket?

The verified numbers, not estimates: brand Zepbound runs $1,249/month and brand Wegovy $1,579 at altRx (Ozempic $1,149; Zepbound KwikPens from $299 first month at ro, then $399-$449 plus membership). The compounded route changes the math entirely: compounded semaglutide from a verified $59/month (welludr) and compounded tirzepatide from $99 - the same active ingredients through licensed telehealth with US state-licensed pharmacies. Full ladder on our cheapest GLP-1 page, checked against every provider's own site.

Shop GLP-1 plans by product

The lowest published plans - cheapest first, conditions under each price.

How do the side effects compare?

Same family, same character: GI effects dominate all three - nausea, constipation, diarrhea, especially during dose increases - because that's how this medication class works. Trial discontinuation rates were broadly similar, and the practical differences are individual: some people tolerate tirzepatide's dual mechanism better, some semaglutide.

Management is identical across them - slow titration, eating patterns, hydration - covered in our side-effects guide. Serious-but-rare warnings (pancreatitis, thyroid C-cell warnings) apply across the class.

What To Know Before Starting GLP-1 Treatment

Before starting GLP-1 treatment, it's important to understand a few key things. These medications require a prescription from a licensed clinician and aren't suitable for everyone. Some people may experience side effects, especially during the first few weeks as the body adjusts.

GLP-1s also tend to work best when combined with basic lifestyle habits like balanced nutrition and regular physical activity.

That's why choosing a provider that offers proper medical screening and ongoing follow-up support is essential for both safety and long-term success.

Woman preparing GLP-1 weight loss injection

Can you switch from Ozempic to Zepbound?

Yes, people do - and here's the part the search results get dangerously wrong: there is no mg-to-mg dose conversion between semaglutide and tirzepatide. They're different molecules with different dose ladders; a prescriber typically starts the new medication at or near its own starting dose and titrates from there, judging by response and tolerability.

Never attempt a DIY conversion. If the switch you actually want is away from brand pricing rather than between molecules, that's a different move - our switching-to-compounded guide covers it.

Which one should you choose?

Decision logic, honestly ordered. Chasing maximum average efficacy with budget for brand: Zepbound leads the trial numbers.

Insurance covering one of them: the covered one usually wins the math - check your formulary first. Self-pay: the compounded route's $59-$99/month changes the entire question, which is why it's our default starting point for cash payers - compare on the ranking.

Diabetes plus weight goals: that's an Ozempic/Mounjaro-label conversation with your clinician. Whichever route: prescription required, titration takes months, and the provider's follow-up quality matters more than the logo on the pen.

Ready to compare weight loss providers?

See how top providers stack up on pricing, medical support, and treatment options.

Medical disclaimer

This page is general information about GLP-1 weight-loss medications such as semaglutide and tirzepatide, published to help you compare services. It is not medical advice, it does not create a doctor-patient relationship, and it is not a substitute for a consultation with a licensed clinician who knows your history. Treatments Hub is not a medical provider, pharmacy or clinic and does not prescribe, sell or dispense medication. Do not start, stop or change any treatment because of something you read here, and do not delay seeking care; in an emergency call 911.

Semaglutide and tirzepatide carry an FDA boxed warning about thyroid C-cell tumours seen in rodents and are not for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, nor for use in pregnancy. Compounded versions sold by telehealth providers are prepared by state-licensed pharmacies and are not FDA-approved products. Where a review or post on this page mentions weight lost, that is one person's result and is not typical; results vary widely.

Medical and scientific statements on this site are checked against the sources linked on the page by our medical content reviewer, who does not choose providers or set prices. Prices, plans and customer reviews are each provider's published figures and customers' own words on the dates stated. We may earn a commission from provider links. The full medical and advertising disclaimer explains all of this in detail.

Sources & medical references

Treatment facts on this page are grounded in regulatory guidance and peer-reviewed research. Pricing and plan details come from each provider's published information. This content is for information only and is not medical advice - always consult a licensed clinician before starting treatment.

  1. 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
  2. 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
  3. 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
  4. 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
  5. 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
  6. 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
  7. 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)